{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:41:05Z","timestamp":1788327665292,"version":"build-2803163510"},"reference-count":94,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-DK115950"],"award-info":[{"award-number":["R01-DK115950"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-DK122280"],"award-info":[{"award-number":["R01-DK122280"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.cgh.2020.04.020","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T12:12:59Z","timestamp":1594642379000},"page":"1748-1758.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Pharmacology, Clinical Effects, and Therapeutic Potential of Cannabinoids for Gastrointestinal and Liver Diseases"],"prefix":"10.1016","volume":"19","author":[{"given":"Daniel B.","family":"Maselli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6472-7514","authenticated-orcid":false,"given":"Michael","family":"Camilleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2020.04.020_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/MEG.0000000000000779","article-title":"Role of cannabis in digestive\u00a0disorders","volume":"29","author":"Goyal","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.04.020_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13370","article-title":"Cannabinoids and gastrointestinal motility: pharmacology, clinical effects, and potential therapeutics in humans","volume":"30","author":"Camilleri","year":"2018","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2020.04.020_bib3","doi-asserted-by":"crossref","first-page":"G78","DOI":"10.1152\/ajpgi.90285.2008","article-title":"Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats","volume":"295","author":"Duncan","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.cgh.2020.04.020_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/sj.bjp.0707486","article-title":"Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation","volume":"153","author":"Wright","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cgh.2020.04.020_bib5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2036.2005.02648.x","article-title":"Endocannabinoids and their receptors in the enteric nervous system","volume":"22","author":"Duncan","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2020.04.020_bib6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.gastro.2005.05.026","article-title":"Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing","volume":"129","author":"Wright","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2020.04.020_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/sj.bjp.0706710","article-title":"Cannabinoid 1 (CB1) receptors coupled to cholinergic motorneurones inhibit neurogenic circular muscle contractility in the human colon","volume":"148","author":"Hinds","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cgh.2020.04.020_bib8","first-page":"G655","article-title":"Endocannabinoids in the gastrointestinal tract","volume":"311","author":"Lee","year":"2016","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cgh.2020.04.020_bib9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bjp.0707481","article-title":"Novel cannabinoid receptors","volume":"152","author":"Brown","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cgh.2020.04.020_bib10","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1053\/j.gastro.2016.04.015","article-title":"The role of the endocannabinoid system in the brain-gut axis","volume":"151","author":"Sharkey","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2020.04.020_bib11","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: a systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2020.04.020_bib12","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1213\/ANE.0000000000002110","article-title":"Selective cannabinoids for chronic neuropathic pain: a systematic review and meta-analysis","volume":"125","author":"Meng","year":"2017","journal-title":"Anesth Analg"},{"key":"10.1016\/j.cgh.2020.04.020_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/15563650.2015.1110590","article-title":"A\u00a0systematic review of\u00a0adverse events arising from the use of synthetic cannabinoids and their associated treatment","volume":"54","author":"Tait","year":"2016","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.cgh.2020.04.020_bib15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fpsyt.2017.00156","article-title":"Synthetic cathinone and cannabinoid designer drugs pose a major risk for public health","volume":"8","author":"Weinstein","year":"2017","journal-title":"Front Psychiatr"},{"key":"10.1016\/j.cgh.2020.04.020_bib17","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jpeds.2017.07.005","article-title":"Unintentional cannabis ingestion in children: a systematic review","volume":"190","author":"Richards","year":"2017","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.cgh.2020.04.020_bib18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2017.08.014","article-title":"Cannabis use during pregnancy: pharmacokinetics and effects on child development","volume":"182","author":"Grant","year":"2018","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cgh.2020.04.020_bib19","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/gut.2003.036350","article-title":"Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse","volume":"53","author":"Allen","year":"2004","journal-title":"Gut"},{"issue":"Suppl A","key":"10.1016\/j.cgh.2020.04.020_bib20","first-page":"44A","article-title":"Guidelines for the use of cannabinoid compounds in chronic pain","volume":"10","author":"Clark","year":"2005","journal-title":"Pain Res Manag"},{"key":"10.1016\/j.cgh.2020.04.020_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/phar.1709","article-title":"Nabilone for the management of pain","volume":"36","author":"Tsang","year":"2016","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cgh.2020.04.020_bib22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.18773\/austprescr.2018.066","article-title":"Nabiximols for multiple sclerosis","volume":"41","year":"2018","journal-title":"Aust Prescr"},{"key":"10.1016\/j.cgh.2020.04.020_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/gut.50.1.19","article-title":"Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease","volume":"50","author":"Zhang","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2020.04.020_bib24","doi-asserted-by":"crossref","first-page":"383.e173","DOI":"10.1111\/j.1365-2982.2011.01868.x","article-title":"Localization of mGluR5, GABAB, GABAA, and cannabinoid receptors on the\u00a0vago-vagal reflex pathway responsible for transient lower\u00a0esophageal sphincter relaxation in humans: an immunohistochemical study","volume":"24","author":"Rohof","year":"2012","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2020.04.020_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1476-5381.2008.00010.x","article-title":"Effect of delta9-tetrahydrocannabinol, a cannabinoid receptor agonist, on the\u00a0triggering of transient lower oesophageal sphincter relaxations\u00a0in dogs and humans","volume":"156","author":"Beaumont","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cgh.2020.04.020_bib26","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1365-2036.2011.04576.x","article-title":"Effect of rimonabant on oesophageal motor function in man","volume":"33","author":"Scarpellini","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2020.04.020_bib27","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1089\/can.2017.0031","article-title":"Review: the role of cannabinoids on esophageal function\u2014what we know thus far","volume":"2","author":"Gotfried","year":"2017","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.cgh.2020.04.020_bib28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.mayocp.2011.10.005","article-title":"Cannabinoid hyperemesis: a case series of 98 patients","volume":"87","author":"Simonetto","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cgh.2020.04.020_bib29","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/phar.1931","article-title":"Pharmacologic treatment of cannabinoid hyperemesis syndrome: a systematic review","volume":"37","author":"Richards","year":"2017","journal-title":"Pharmacotherapy"},{"issue":"Suppl 2","key":"10.1016\/j.cgh.2020.04.020_bib30","article-title":"Role of chronic cannabis use: cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome","volume":"31","author":"Venkatesan","year":"2019","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2020.04.020_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13174","article-title":"Cyclic vomiting syndrome is a prevalent and under-recognized condition in the gastroenterology outpatient clinic","volume":"30","author":"Sagar","year":"2018","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2020.04.020_bib32","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.cgh.2019.07.039","article-title":"Patterns of cannabis use in patients with cyclic vomiting syndrome","volume":"18","author":"Venkatesan","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.04.020_bib33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/apt.12822","article-title":"Efficacy of the neurokinin-1 receptor antagonist aprepitant in children with cyclical vomiting syndrome","volume":"40","author":"Cristofori","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2020.04.020_bib34","article-title":"Emerging role of aprepitant in cannabis hyperemesis syndrome","volume":"11","author":"Parvataneni","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.cgh.2020.04.020_bib35","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.drugalcdep.2018.12.009","article-title":"Trends in marijuana use among pregnant women with and without nausea and vomiting in pregnancy, 2009-2016","volume":"196","author":"Young-Wolff","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.cgh.2020.04.020_bib36","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1097\/AOG.0000000000002878","article-title":"Marijuana use in pregnancy and while breastfeeding","volume":"132","author":"Metz","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cgh.2020.04.020_bib37","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/jgh.12346","article-title":"Decreased enteric fatty acid amide hydrolase activity is associated with colonic inertia in slow transit constipation","volume":"29","author":"Zhang","year":"2014","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.04.020_bib38","first-page":"332","article-title":"Role of orphan G protein-coupled receptor 55 in diabetic gastroparesis in mice","volume":"66","author":"Lin","year":"2014","journal-title":"Sheng Li Xue Bao"},{"key":"10.1016\/j.cgh.2020.04.020_bib39","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2982.2006.00834.x","article-title":"Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study","volume":"18","author":"Esfandyari","year":"2006","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2020.04.020_bib40","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/sj.bjp.0705783","article-title":"Involvement of cannabinoid receptors in gut motility and visceral perception","volume":"141","author":"Hornby","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cgh.2020.04.020_bib41","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1111\/bph.13114","article-title":"Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation","volume":"172","author":"Bashashati","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cgh.2020.04.020_bib42","first-page":"137","article-title":"Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study","volume":"293","author":"Esfandyari","year":"2007","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cgh.2020.04.020_bib43","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.14309\/ajg.0000000000000441","article-title":"Relationship between recreational marijuana use and bowel function in a nationwide cohort study","volume":"114","author":"Adejumo","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.020_bib44","article-title":"Marijuana use in patients with symptoms of gastroparesis: prevalence, patient characteristics, and perceived benefit","author":"Parkman","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2020.04.020_bib45","article-title":"Impact of cannabinoids on symptoms of refractory gastroparesis: a single-center experience","volume":"11","author":"Barbash","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.cgh.2020.04.020_bib46","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.bjp.0707682","article-title":"The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet","volume":"153","author":"Di Marzo","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cgh.2020.04.020_bib47","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/ecco-jcc\/jjy185","article-title":"Cannabis, cannabinoids, and the endocannabinoid system: is there therapeutic potential for inflammatory bowel disease?","volume":"13","author":"Ambrose","year":"2019","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2020.04.020_bib48","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI200419465","article-title":"The endogenous cannabinoid system protects against colonic inflammation","volume":"113","author":"Massa","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cgh.2020.04.020_bib49","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/ibd\/izz017","article-title":"Palmitoylethanolamide and cannabidiol prevent inflammation-induced hyperpermeability of the human gut in\u00a0vitro and in\u00a0vivo: a randomized, placebo-controlled, double-blind controlled trial","volume":"25","author":"Couch","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2020.04.020_bib50","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.drugalcdep.2015.08.035","article-title":"Patterns of cannabis use in patients with inflammatory bowel disease: a population based analysis","volume":"156","author":"Weiss","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.cgh.2020.04.020_bib51","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/01.MIB.0000440982.79036.d6","article-title":"Cannabis use provides symptom relief in patients with inflammatory bowel disease\u00a0but\u00a0is associated with worse disease prognosis in patients with\u00a0Crohn's disease","volume":"20","author":"Storr","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2020.04.020_bib52","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cgh.2013.04.034","article-title":"Cannabis induces a clinical response in patients with Crohn\u2019s disease: a prospective placebo-controlled study","volume":"11","author":"Naftali","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.04.020_bib53","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s10620-017-4540-z","article-title":"Low-dose cannabidiol is safe but not effective in the treatment for Crohn's disease, a randomized controlled trial","volume":"62","author":"Naftali","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2020.04.020_bib54","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/ibd\/izy002","article-title":"A\u00a0randomized, double-blind, placebo-controlled, parallel-group, pilot study of cannabidiol-rich botanical extract in the symptomatic treatment of ulcerative colitis","volume":"24","author":"Irving","year":"2018","journal-title":"Inflamm Bowel Dis"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2020.04.020_bib55","doi-asserted-by":"crossref","first-page":"S665","DOI":"10.1016\/S0016-5085(19)38567-1","article-title":"Safety and efficacy of olorinab, a peripherally restricted, highly selective, cannabinoid receptor 2 agonist in a phase 2A study in chronic abdominal pain associated with Crohn\u2019s disease","volume":"156","author":"Yacyshyn","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2020.04.020_bib56","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1210\/me.2015-1062","article-title":"Minireview: from the bench, toward the clinic\u2014therapeutic opportunities for cannabinoid receptor modulation","volume":"29","author":"Picone","year":"2015","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.cgh.2020.04.020_bib57","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ceca.2005.10.005","article-title":"Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell","volume":"39","author":"Juan-Pic\u00f3","year":"2006","journal-title":"Cell Calcium"},{"issue":"Suppl 5","key":"10.1016\/j.cgh.2020.04.020_bib58","first-page":"137","article-title":"Cannabinoids in acute gastric damage and pancreatitis","volume":"57","author":"Dembi\u0144ski","year":"2006","journal-title":"J\u00a0Physiol Pharmacol"},{"key":"10.1016\/j.cgh.2020.04.020_bib59","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1053\/j.gastro.2007.02.035","article-title":"Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis","volume":"132","author":"Michalski","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2020.04.020_bib60","first-page":"579","article-title":"Cannabinoid-induced pancreatitis: a case series","volume":"8","author":"Wargo","year":"2007","journal-title":"J\u00a0Pancreas"},{"key":"10.1016\/j.cgh.2020.04.020_bib61","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/ajg.2015.197","article-title":"Cannabinoid receptor agonist namisol does not affect cytokine levels in chronic pancreatitis patients","volume":"110","author":"Utomo","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.020_bib62","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cgh.2016.09.147","article-title":"Tetrahydrocannabinol does not reduce pain in patients with chronic abdominal pain in a phase 2 placebo-controlled study","volume":"15","author":"de Vries","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.04.020_bib63","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.cgh.2019.01.018","article-title":"Effects of medical cannabis on use of opioids and hospital visits by patients with painful chronic pancreatitis","volume":"17","author":"Barlowe","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.04.020_bib64","first-page":"1","article-title":"Potential use of cannabinoids for the treatment of pancreatic cancer","volume":"5","author":"Sharafi","year":"2019","journal-title":"J\u00a0Pancreat Cancer"},{"key":"10.1016\/j.cgh.2020.04.020_bib65","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2826.2008.01679.x","article-title":"The endocannabinoid system and liver diseases","volume":"20","author":"Caraceni","year":"2008","journal-title":"J\u00a0Neuroendocrinol"},{"key":"10.1016\/j.cgh.2020.04.020_bib66","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41575-019-0233-8","article-title":"Hepatocyte-stellate cell synapse in alcohol-induced steatosis: another role for endocannabinoids","volume":"17","author":"Argemi","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.04.020_bib67","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cmet.2019.08.001","article-title":"Glutamate signaling in hepatic stellate cells drives alcoholic steatosis","volume":"30","author":"Choi","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.cgh.2020.04.020_bib68","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3390\/ijms20102516","article-title":"Endocannabinoid system in hepatic glucose metabolism, fatty liver disease, and cirrhosis","volume":"20","author":"Bazwinsky-Wutschke","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cgh.2020.04.020_bib69","first-page":"52","article-title":"The role of cannabinoids in the setting of cirrhosis","volume":"5","author":"Dibba","year":"2018","journal-title":"Medicines (Basel)"},{"key":"10.1016\/j.cgh.2020.04.020_bib70","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijid.2017.03.008","article-title":"Hepatic expression of cannabinoid receptors CB1 and CB2 correlate with fibrogenesis in patients with chronic hepatitis B","volume":"59","author":"Dai","year":"2017","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cgh.2020.04.020_bib71","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/hep.20733","article-title":"Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C","volume":"42","author":"H\u00e9zode","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2020.04.020_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012841","article-title":"Hepatitis C virus induces the cannabinoid receptor 1","volume":"5","author":"van der Poorten","year":"2010","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2020.04.020_bib73","doi-asserted-by":"crossref","first-page":"S382","DOI":"10.1016\/S0016-5085(19)37805-9","article-title":"Olorinab (formerly APD371), a peripherally restricted, highly selective, full agonist of the cannabinoid receptor 2 (CB2), reduces visceral hypersensitivity in animal models","volume":"156","author":"Castro","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2020.04.020_bib74","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/cid\/civ217","article-title":"Cannabis use and reduced risk of insulin resistance in HIV-HCV infected patients: a longitudinal analysis (ANRS CO13 HEPAVIH)","volume":"61","author":"Carrieri","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2020.04.020_bib75","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/jvh.12797","article-title":"Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus-co-infected patients (ANRS CO13-HEPAVIH)","volume":"25","author":"Nordmann","year":"2018","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cgh.2020.04.020_bib76","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0083-6729(09)81019-4","article-title":"Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis","volume":"81","author":"Pandey","year":"2009","journal-title":"Vitam Horm"},{"key":"10.1016\/j.cgh.2020.04.020_bib77","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3959(03)00331-2","article-title":"Lack of analgesic efficacy of oral delta-9-tetrahydrocannabinol in postoperative pain","volume":"106","author":"Buggy","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.cgh.2020.04.020_bib78","doi-asserted-by":"crossref","first-page":"E755","DOI":"10.36076\/ppj.20.5.E755","article-title":"Efficacy of cannabis-based medicines for pain management: a systematic review and meta-analysis of randomized controlled trials","volume":"20","author":"Aviram","year":"2017","journal-title":"Pain Physician"},{"key":"10.1016\/j.cgh.2020.04.020_bib79","first-page":"CD012182","article-title":"Cannabis-based medicines for chronic neuropathic pain in adults","volume":"3","author":"M\u00fccke","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cgh.2020.04.020_bib80","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archgenpsychiatry.2008.519","article-title":"Distinct effects of \u03949-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing","volume":"66","author":"Fusar-Poli","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.cgh.2020.04.020_bib81","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/apt.13958","article-title":"Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome","volume":"45","author":"Cremon","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2020.04.020_bib82","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13688","article-title":"\u03bc-opioid receptor, \u03b2-endorphin, and cannabinoid receptor-2 are increased in the colonic mucosa of irritable bowel syndrome patients","volume":"31","author":"Dothel","year":"2019","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2020.04.020_bib83","first-page":"CD009464","article-title":"Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy","volume":"11","author":"Smith","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cgh.2020.04.020_bib84","first-page":"CD007786","article-title":"Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood","volume":"9","author":"Phillips","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cgh.2020.04.020_bib85","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ptr.5975","article-title":"Cannabinoids for nausea and vomiting related to chemotherapy: overview of systematic reviews","volume":"32","author":"Schussel","year":"2018","journal-title":"Phytother Res"},{"key":"10.1016\/j.cgh.2020.04.020_bib86","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/0003489415612801","article-title":"Improving quality of life with nabilone during radiotherapy treatments for head and neck cancers: a randomized double-blind placebo-controlled trial","volume":"125","author":"Cote","year":"2016","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.cgh.2020.04.020_bib87","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s12630-017-0814-3","article-title":"A\u00a0randomized-controlled trial of nabilone for the prevention of acute postoperative nausea and vomiting in elective surgery","volume":"64","author":"Levin","year":"2017","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.cgh.2020.04.020_bib88","unstructured":"Ho C, MacDougall D. Nabilone for the treatment of nausea and\u00a0vomiting or anorexia: a review of clinical effectiveness and\u00a0guidelines [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2019 Feb 27. PMID:\u00a031556979."},{"key":"10.1016\/j.cgh.2020.04.020_bib89","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1744-8069-10-66","article-title":"Cannabinoid receptor 2 agonist attenuates pain related behavior in rats with chronic alcohol\/high fat diet induced pancreatitis","volume":"10","author":"Zhang","year":"2014","journal-title":"Mol Pain"},{"key":"10.1016\/j.cgh.2020.04.020_bib90","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1053\/j.gastro.2019.01.215","article-title":"Olorinab, a peripherally restricted, highly selective agonist of the cannabinoid receptor type 2 for the management of visceral pain in inflammatory bowel disease (IBD): preclinical and early clinical development","volume":"156","author":"Lindstrom","year":"2019","journal-title":"Gastroenterology"},{"issue":"Suppl","key":"10.1016\/j.cgh.2020.04.020_bib91","first-page":"S47","article-title":"Safety, tolerability, and pharmacokinetics of APD371, a highly selective CB2 agonist, in healthy adults","volume":"19","author":"Jones","year":"2018","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.cgh.2020.04.020_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2018.02.016","article-title":"The non-psychoactive phytocannabinoid cannabidiol (CBD) attenuates pro-inflammatory mediators, T cell infiltration, and thermal sensitivity following spinal cord injury in mice","volume":"329","author":"Li","year":"2018","journal-title":"Cell Immunol"},{"key":"10.1016\/j.cgh.2020.04.020_bib93","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1254\/jphs.FP0071599","article-title":"Pharmacological evaluation of a novel cannabinoid 2 (CB2) ligand, PF-03550096, in\u00a0vitro and in\u00a0vivo by using a rat model of visceral hypersensitivity","volume":"106","author":"Kikuchi","year":"2008","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.cgh.2020.04.020_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082562","article-title":"Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy","volume":"8","author":"Preissner","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2020.04.020_bib95","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.lfs.2011.05.018","article-title":"Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes","volume":"89","author":"Jiang","year":"2011","journal-title":"Life Sci"},{"key":"10.1016\/j.cgh.2020.04.020_bib96","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/gutjnl-2019-320325","article-title":"Actionable biomarkers: the key to resolving disorders of gastrointestinal function","volume":"69","author":"Camilleri","year":"2020","journal-title":"Gut"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356520305048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356520305048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:12:49Z","timestamp":1778818369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356520305048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":94,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1542356520305048"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2020.04.020","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacology, Clinical Effects, and Therapeutic Potential of Cannabinoids for Gastrointestinal and Liver Diseases","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2020.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the AGA Institute","name":"copyright","label":"Copyright"}]}}